ArticleJournal of clinical laboratory analysis2021

Tumor necrosis factor alpha-an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?

Moritz Mirna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.